EV/EBITDA:
-6.54-0.53(-8.82%)Summary
- As of today (August 22, 2025), ELVN EV/EBITDA is -6.54, with a fall of -0.53 (-8.82%) during the most recent trading session on August 22, 2025.
- Over the past year, ELVN EV/EBITDA has increased by +1.37 (+17.32%).
- ELVN EV/EBITDA is now -308.28% below its all-time high of 3.14.
Performance
ELVN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ELVN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -8.8% | +8.7% | +5.1% |
| 1 m1 month | +5.3% | -5.3% | -3.3% |
| 3 m3 months | -34.9% | +39.6% | +24.3% |
| 6 m6 months | +9.5% | -1.1% | -4.4% |
| ytdytd | +13.5% | -5.4% | -7.3% |
| 1 y1 year | +17.3% | -3.2% | -8.9% |
| 5 y5 years | -1621.0% | +7815.3% | -21.9% |
ELVN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -4.90 | -33.5% | -7.32 | +10.7% |
| 3 m | 3-month | -4.51 | -45.0% | -9.76 | +33.0% |
| 6 m | 6-month | -4.02 | -62.7% | -9.76 | +33.0% |
| 1 y | 1-year | -4.02 | -62.7% | -11.51 | +43.2% |
| 3 y | 3-year | 1.95 | -435.4% | -28.20 | +76.8% |
| 5 y | 5-year | 1.95 | -435.4% | -28.20 | +76.8% |
| alltime | all time | 3.14 | -308.3% | -28.20 | +76.8% |
ELVN EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -6.54(-13.5%) |
| 2024 | -7.56(+97.4%) |
| 2023 | -3.83(-299.5%) |
| Date | Value |
|---|---|
| 2022 | 1.92(+30.6%) |
| 2021 | 1.47(-835.0%) |
| 2020 | -0.20 |
FAQ
- What is Enliven Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Enliven Therapeutics, Inc.?
- What is ELVN EV/EBITDA year-to-date change?
- What is Enliven Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Enliven Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of ELVN is -6.54
What is the all time high EV/EBITDA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high EV/EBITDA is 3.14
What is ELVN EV/EBITDA year-to-date change?
Enliven Therapeutics, Inc. EV/EBITDA has changed by +1.02 (+13.49%) since the beginning of the year
What is Enliven Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, ELVN EV/EBITDA has changed by +1.37 (+17.32%)